{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:58Z","timestamp":1764402538193},"reference-count":20,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.057","type":"journal-article","created":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T14:01:34Z","timestamp":1333288894000},"page":"3360-3368","source":"Crossref","is-referenced-by-count":9,"title":["Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study"],"prefix":"10.1016","volume":"30","author":[{"given":"Archana","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Varman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Luber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antigona","family":"Tomovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (RR-15)","key":"10.1016\/j.vaccine.2012.03.057_bib0005","first-page":"1","article-title":"General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP)","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.03.057_bib0010","first-page":"1","article-title":"General recommendations on immunization\u2014recommendations of the advisory committee on immunization practices (ACIP)","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Surveill Summ"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2012.03.057_bib0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pedhc.2007.09.004","article-title":"Societal impact of combination vaccines: experiences of physicians, nurses, and parents","volume":"22","author":"Koslap-Petraco","year":"2008","journal-title":"J Pediatr Health Care"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2012.03.057_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mph.2003.42","article-title":"Communicating the benefits of combination vaccines to parents and health care providers","volume":"17","author":"Koslap-Petraco","year":"2003","journal-title":"J Pediatr Health Care"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.03.057_bib0025","first-page":"506","article-title":"Combination vaccine use and vaccination quality in a managed care population","volume":"13","author":"Happe","year":"2007","journal-title":"Am J Manag Care"},{"issue":"January (1 Suppl.)","key":"10.1016\/j.vaccine.2012.03.057_bib0030","first-page":"S6","article-title":"Benefits of combination vaccines: effective vaccination on a simplified schedule","volume":"9","author":"Dodd","year":"2003","journal-title":"Am J Manag Care"},{"issue":"November (11 Suppl.)","key":"10.1016\/j.vaccine.2012.03.057_bib0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","article-title":"Principles of pediatric combination vaccines and practical issues related to use in clinical practice","volume":"20","author":"Decker","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.057_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006454-200005000-00006","article-title":"Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis\/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination","volume":"19","author":"Rennels","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.03.057_bib0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006454-199709000-00009","article-title":"Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis\/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.03.057_bib0050","unstructured":"U.S. National Institutes of Health (NIH) Web Site. Safety and Immune Response of Different Pediatric Combination Vaccines. [cited 2012 March 1]; Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00255047?term=M5A10&rank=1."},{"key":"10.1016\/j.vaccine.2012.03.057_bib0055","unstructured":"Pentacel\u00ae [prescribing information]. Swiftwater, PA, USA: Sanofi Pasteur Inc.; 2009 [cited 2012 March 1], Available from: https:\/\/www.vaccineshoppe.com\/image.cfm?doc_id=11169&image_type=product_pdf."},{"key":"10.1016\/j.vaccine.2012.03.057_bib0060","unstructured":"Quadracel\u00ae [product monograph]. Toronto, Ontario, Canada: Sanofi Pasteur Limited; 2008 [cited 2012 March 1], Available from: https:\/\/www.vaccineshoppecanada.com\/secure\/PDFs\/CA\/Quadracel_E.pdf."},{"key":"10.1016\/j.vaccine.2012.03.057_bib0065","unstructured":"DAPTACEL\u00ae [prescribing information]. Toronto, Ontario, Canada: Sanofi Pasteur Limited; 2011 [cited 2012 March 1], Available from: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM103037.pdf."},{"issue":"March (11)","key":"10.1016\/j.vaccine.2012.03.057_bib0070","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2010.06.037","volume":"29","author":"Bernstein","year":"2011","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.03.057_bib0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.057_bib0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4049\/jimmunol.120.3.866","article-title":"Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b","volume":"120","author":"Anderson","year":"1978","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.057_bib0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/INF.0b013e318187d047","article-title":"Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population","volume":"28","author":"Happe","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.057_bib0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2012.03.057_bib0095","first-page":"823","article-title":"Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type b","volume":"307","author":"Sun","year":"2012","journal-title":"JAMA"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.057_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.2007-3317","article-title":"Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial","volume":"123","author":"Guerra","year":"2009","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:05:58Z","timestamp":1687367158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":20,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X12004495"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}